Search

Obafemi Oludayo Sosanya

Examiner (ID: 19368, Phone: (571)270-1069 , Office: P/2486 )

Most Active Art Unit
2486
Art Unit(s)
2486, 2423
Total Applications
511
Issued Applications
376
Pending Applications
0
Abandoned Applications
137

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18877543 [patent_doc_number] => 20240000912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES [patent_app_type] => utility [patent_app_number] => 18/034239 [patent_app_country] => US [patent_app_date] => 2021-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034239 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/034239
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES Oct 31, 2021 Pending
Array ( [id] => 20453039 [patent_doc_number] => 12516089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Bacteria based protein delivery [patent_app_type] => utility [patent_app_number] => 18/249626 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37897 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249626 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/249626
Bacteria based protein delivery Oct 25, 2021 Issued
Array ( [id] => 20453039 [patent_doc_number] => 12516089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Bacteria based protein delivery [patent_app_type] => utility [patent_app_number] => 18/249626 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37897 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249626 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/249626
Bacteria based protein delivery Oct 25, 2021 Issued
Array ( [id] => 18771170 [patent_doc_number] => 20230365982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => STANDARDISED CYANOBACTERIAL STRAIN ENGINEERING [patent_app_type] => utility [patent_app_number] => 18/246564 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246564 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/246564
STANDARDISED CYANOBACTERIAL STRAIN ENGINEERING Sep 23, 2021 Pending
Array ( [id] => 18895227 [patent_doc_number] => 20240010712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN [patent_app_type] => utility [patent_app_number] => 18/245884 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245884 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/245884
ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN Sep 19, 2021 Pending
Array ( [id] => 18647827 [patent_doc_number] => 20230293602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => COMBINATION IMMUNOTHERAPY METHODS FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 18/042231 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042231 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042231
COMBINATION IMMUNOTHERAPY METHODS FOR THE TREATMENT OF CANCER Aug 19, 2021 Pending
Array ( [id] => 18610874 [patent_doc_number] => 20230277604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => THERAPEUTIC AGENT OR DIAGNOSTIC AGENT FOR CANCER [patent_app_type] => utility [patent_app_number] => 18/017934 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017934 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017934
THERAPEUTIC AGENT OR DIAGNOSTIC AGENT FOR CANCER Jul 26, 2021 Pending
Array ( [id] => 18420460 [patent_doc_number] => 20230174922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL [patent_app_type] => utility [patent_app_number] => 18/014004 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17326 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014004 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/014004
MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL Jul 6, 2021 Pending
Array ( [id] => 18724375 [patent_doc_number] => 20230338519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/998693 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22645 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998693 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998693
FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY May 13, 2021 Pending
Array ( [id] => 18057979 [patent_doc_number] => 20220389065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 17/789300 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789300
ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT May 6, 2021 Pending
Array ( [id] => 18057979 [patent_doc_number] => 20220389065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 17/789300 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789300
ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT May 6, 2021 Pending
Array ( [id] => 18829686 [patent_doc_number] => 20230398210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE [patent_app_type] => utility [patent_app_number] => 17/917010 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917010 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917010
IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE Apr 8, 2021 Pending
Array ( [id] => 18829686 [patent_doc_number] => 20230398210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE [patent_app_type] => utility [patent_app_number] => 17/917010 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917010 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917010
IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE Apr 8, 2021 Pending
Array ( [id] => 18497661 [patent_doc_number] => 20230220326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/796565 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796565 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/796565
VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME Mar 4, 2021 Pending
Array ( [id] => 18497661 [patent_doc_number] => 20230220326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/796565 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796565 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/796565
VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME Mar 4, 2021 Pending
Array ( [id] => 18325303 [patent_doc_number] => 20230123431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => METABOLIC ENGINEERING FOR PRODUCTION OF LIPOIC ACID [patent_app_type] => utility [patent_app_number] => 17/905592 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905592 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905592
METABOLIC ENGINEERING FOR PRODUCTION OF LIPOIC ACID Mar 1, 2021 Pending
Array ( [id] => 18257260 [patent_doc_number] => 20230084300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS [patent_app_type] => utility [patent_app_number] => 17/904155 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904155 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904155
PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS Feb 11, 2021 Pending
Array ( [id] => 18312656 [patent_doc_number] => 20230116556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST [patent_app_type] => utility [patent_app_number] => 17/794744 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794744 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/794744
INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST Jan 21, 2021 Pending
Array ( [id] => 18244100 [patent_doc_number] => 20230076411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => LASSO PEPTIDES FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/790103 [patent_app_country] => US [patent_app_date] => 2021-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49096 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790103 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/790103
LASSO PEPTIDES FOR TREATMENT OF CANCER Jan 4, 2021 Pending
Array ( [id] => 18208214 [patent_doc_number] => 20230054472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => SAMPLE PREPARATION AND MICROBIAL ANALYSIS [patent_app_type] => utility [patent_app_number] => 17/788137 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14929 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788137 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/788137
SAMPLE PREPARATION AND MICROBIAL ANALYSIS Dec 22, 2020 Abandoned
Menu